US’s screwworm fight hinges on flies, but sterilized output is the bottleneck
A plan to crash flesh-eating screwworms relies on sterile fly production that the US can’t scale right now.

The US has a plan to combat screwworms by releasing sterilized flies, which can suppress local flesh-eating outbreaks. The catch for decision-makers: the US currently has limited capacity to produce those sterilized flies.
The US plan to combat flesh-eating screwworms is surprisingly simple in concept: release sterilized flies, and let population crashes do the rest. The immediate logic is clean. If enough breeding adults are rendered sterile, the local screwworm population cannot reproduce effectively, and the infestation level drops.
But there is a hard constraint sitting underneath the pretty biology. The US currently has limited capacity to produce the sterilized flies it would need. In other words, the plan works in theory, but scale is the problem. That mismatch between what the strategy can do and what the system can currently produce is the real tension, and it matters because screwworms are not just an odd rural threat. They are a high-impact animal health issue, and outbreaks force expensive, disruptive responses from the people who manage livestock and biosecurity.
So how does this play out operationally? Think of the sterile fly program like a supply chain, not a one-off science project. Even if the sterilization method is proven, the bottleneck becomes throughput: how many sterilized flies can be produced, how quickly, and how reliably the program can keep doing it at the regional scale required. When the capacity is limited, the campaign can become constrained to certain zones, certain time windows, or certain outbreak thresholds, rather than being deployed as broadly as the threat demands.
This is also where incentives and planning cycles start to matter. Outbreak prevention is often easier to budget than outbreak recovery, but production constraints can force a more reactive posture. If decision-makers cannot ramp sterile fly output, they may have to choose between smaller interventions now and more costly damage later. That choice is especially painful for boards, operators, and funders because the benefits of preemptive action are real but harder to “see” until the outbreak either fails to happen or worsens.
Regulatory framing adds another layer. Programs that involve releasing insects typically live in a world of permits, safety reviews, environmental considerations, and strict operational standards, because the consequence of getting it wrong is not just ineffective pest control. It is an ecological and public trust issue. The source you provided keeps the focus on the plan itself and the capacity limitation, but the practical reality is that regulatory approvals can shape how fast a program can grow. If capacity is capped and approvals take time, the system can get stuck in a slower feedback loop, where the threat evolves faster than production can.
There is also a broader, second-order implication for anyone tracking agricultural biotech or public health tooling. This is not a single-company “breakthrough moment.” It is an industrial capability problem. Capacity constraints can mean that the “technology” is not the limiting factor, even when the intervention is effective. The limiting factor is manufacturing scale, logistics, and program continuity. That shifts how leaders evaluate solutions: not just whether the approach works, but whether the operating model can sustain it.
Finally, this kind of program tends to reveal who is holding the power in a coalition. When sterilized fly production is limited, the entity that can produce and supply the flies effectively sets the pace for the whole response. That means the stakes are not only about biology. They are about coordinating planning across agencies, local stakeholders, and any organizations involved in outbreak readiness. If your job is to protect herds, stabilize supply, or manage risk, you care about whether the system can deliver the intervention when and where it is needed.
Bottom line: the US plan to combat screwworms by releasing sterilized flies is built for population suppression, but the US currently has limited capacity to produce those flies. That bottleneck is the difference between a potentially scalable public strategy and a constrained program that can only go as far as production allows.
This story's Key Insights and Take-aways are locked.
Create a free account to unlock Executive Actions for one credit.
Register to UnlockAlways free for Executives Club members. Join the Club
More in Technology

OpenAI ships Lockdown Mode to cut prompt injection leaks from ChatGPT
Lockdown Mode does not make ChatGPT invulnerable, but it aims to lower the odds sensitive data gets shared.

Hidden Folks 2 is coming next year, expanding hand-drawn searching to PC and mobile
The next iteration of Hidden Folks targets PC and mobile first, with Nintendo Switch as a possible later move.

GOG apologizes after a June 5 email mixed Nazi SS symbols into a Slavic game promo
A “series of mistakes” turned a newsletter into a reputational risk for GOG, raising new QA and compliance questions for digital storefronts.
